200 related articles for article (PubMed ID: 33125686)
1. Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases.
Oliveira DVNP; Prahm KP; Christensen IJ; Hansen A; Høgdall CK; Høgdall EV
Reprod Sci; 2021 Mar; 28(3):757-765. PubMed ID: 33125686
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profile association with poor prognosis in epithelial ovarian cancer patients.
Oliveira DVNP; Prahm KP; Christensen IJ; Hansen A; Høgdall CK; Høgdall EV
Sci Rep; 2021 Mar; 11(1):5438. PubMed ID: 33686173
[TBL] [Abstract][Full Text] [Related]
3. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
5. Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition.
Fejzo MS; Chen HW; Anderson L; McDermott MS; Karlan B; Konecny GE; Slamon DJ
Gynecol Oncol; 2021 Feb; 160(2):539-546. PubMed ID: 33229045
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
7. Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data.
Irodi A; Rye T; Herbert K; Churchman M; Bartos C; Mackean M; Nussey F; Herrington CS; Gourley C; Hollis RL
BJOG; 2020 Oct; 127(11):1409-1420. PubMed ID: 32285600
[TBL] [Abstract][Full Text] [Related]
8. Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
Sallinen H; Janhonen S; Pölönen P; Niskanen H; Liu OH; Kivelä A; Hartikainen JM; Anttila M; Heinäniemi M; Ylä-Herttuala S; Kaikkonen MU
BMC Cancer; 2019 Nov; 19(1):1121. PubMed ID: 31744494
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
Prahm KP; Høgdall C; Karlsen MA; Christensen IJ; Novotny GW; Høgdall E
PLoS One; 2018; 13(11):e0207319. PubMed ID: 30475821
[TBL] [Abstract][Full Text] [Related]
10. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor.
Chu ZP; Dai J; Jia LG; Li J; Zhang Y; Zhang ZY; Yan P
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8145-8150. PubMed ID: 30556852
[TBL] [Abstract][Full Text] [Related]
13. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
14. Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer.
Koti M; Gooding RJ; Nuin P; Haslehurst A; Crane C; Weberpals J; Childs T; Bryson P; Dharsee M; Evans K; Feilotter HE; Park PC; Squire JA
BMC Cancer; 2013 Nov; 13():549. PubMed ID: 24237932
[TBL] [Abstract][Full Text] [Related]
15. [Can new molecular profiles in epithelial ovarian cancer modify therapeutics?].
Lavoué V; Rousselin A; Delplanque S; Pinsard M; Henno S; Foucher F; Levêque J; de la Motte Rouge T
J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):107-112. PubMed ID: 28403964
[TBL] [Abstract][Full Text] [Related]
16. Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance.
Liu M; Zhang H; Li Y; Wang S
Cancer Biother Radiopharm; 2022 Apr; 37(3):186-198. PubMed ID: 35133881
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
18. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A
BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763
[TBL] [Abstract][Full Text] [Related]
19. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
[TBL] [Abstract][Full Text] [Related]
20. Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
Lopacinska-Jørgensen J; Oliveira DVNP; Wayne Novotny G; Høgdall CK; Høgdall EV
PLoS One; 2021; 16(7):e0255142. PubMed ID: 34320033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
